AstraZeneca: Creating a Culture of Innovation

Sep 7, 2023

Pascal Soriot, the CEO of AstraZeneca, talks about how AI is changing drug development, the significance of ‘smart chemo’ and why real innovation requires taking risks.

WATCH: Mark Purcell speaks with Pascal Soriot


When Pascal Soriot took the helm at AstraZeneca in 2012, the company was grappling with patent expirations, a lackluster pipeline and poor R&D productivity. Soriot's strategy? Create a culture of risk-taking to spark real innovation.


In the latest episode of Exceptional Leaders / Exceptional Ideas, European Biopharmaceuticals analyst Mark Purcell sits down with Soriot to discuss how “smart chemotherapy” is revolutionizing cancer treatment, why AI is changing every stage of drug development and what he thinks about the future of healthcare.

More Exceptional Leaders

Watch other episodes in this series from Morgan Stanley Research, as the firm’s equity analysts sit down with business leaders at world-class global companies to unpack broad foundational changes in sectors, industries and markets.

More Insights